CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales	$ 429	$ 769	$ 1,603	$ 2,167
Costs and expenses:
Cost of products sold	(123)	(443)	(478)	(1,229)
Research and development expense	(16,810)	(13,946)	(49,606)	(38,135)
Selling, general and administrative expense	(5,761)	(6,977)	(16,448)	(19,656)
Operating loss	(22,265)	(20,597)	(64,929)	(56,853)
Other non-operating income, net	147	123	386	637
Interest and amortization of debt discount and expense	(15)	(11)	(63)	(39)
Net foreign exchange (losses)/gains	(83)	(1,290)	(611)	(457)
Fair value movement of derivatives	7	(19)	15	(54)
Loss before income taxes from continuing operations	(22,209)	(21,794)	(65,202)	(56,766)
Income tax (expense)/benefit	0	0	0	0
Loss after income tax	(22,209)	(21,794)	(65,202)	(56,766)
Total (loss)/gain is attributable to:
Non-controlling interests	35	64	(260)	149
Stockholders of the Company	(22,244)	(21,858)	(64,942)	(56,915)
Loss after income tax	$ (22,209)	$ (21,794)	$ (65,202)	$ (56,766)
Share information
Basic loss per share (in Dollars per share)	$ (0.62)	$ (1.07)	$ (1.8)	$ (2.97)
Diluted loss per share (in Dollars per share)	$ (0.62)	$ (1.07)	$ (1.8)	$ (2.97)